Sirtuin 3
Sirtuin 3 (SIRT3) is a member of the sirtuin family of proteins, known for their roles in regulating cellular processes through deacetylation of proteins. SIRT3 is located within the mitochondria, where it functions as a major mitochondrial deacetylase. This enzyme is involved in various metabolic processes, including the regulation of the Krebs cycle, fatty acid oxidation, and the response to oxidative stress. SIRT3 has garnered significant interest due to its implications in aging, metabolic regulation, and its potential role in various diseases.
Function[edit]
SIRT3 is primarily found in the mitochondria, the energy-producing organelles in cells. It deacetylates and activates several enzymes involved in metabolic pathways, enhancing their efficiency. For instance, SIRT3 deacetylates and activates isocitrate dehydrogenase 2 (IDH2) and succinate dehydrogenase (SDH), both of which are key enzymes in the Krebs cycle. This activation helps in maintaining the energy balance within cells. Additionally, SIRT3 regulates the activity of enzymes involved in fatty acid oxidation, promoting the use of fats as an energy source.
Beyond its metabolic functions, SIRT3 plays a crucial role in the cellular response to oxidative stress. It activates superoxide dismutase 2 (SOD2), an enzyme that detoxifies superoxide radicals, thereby protecting cells from damage induced by reactive oxygen species (ROS).
Clinical Significance[edit]
The role of SIRT3 in metabolism and oxidative stress response has implications for various diseases and conditions. Reduced SIRT3 activity has been associated with metabolic syndrome, obesity, and type 2 diabetes. On the other hand, increased SIRT3 expression has been linked to extended lifespan in some organisms, suggesting a potential role in aging and age-related diseases.
SIRT3's involvement in regulating oxidative stress also makes it a candidate for therapeutic targeting in diseases characterized by mitochondrial dysfunction, such as neurodegenerative diseases, cardiovascular diseases, and certain types of cancer. Research is ongoing to explore SIRT3 activators or enhancers as potential therapeutic agents.
Genetics[edit]
The gene encoding SIRT3 is located on human chromosome 11p15.5. Variants within or near the SIRT3 gene have been studied for their association with metabolic diseases and longevity. Understanding the genetic regulation of SIRT3 expression and activity could provide insights into its role in health and disease.
Research Directions[edit]
Current research on SIRT3 focuses on elucidating its precise mechanisms of action and its broader implications in cellular metabolism, aging, and disease. Studies are also exploring the potential of SIRT3 as a biomarker for mitochondrial health and as a target for therapeutic interventions aimed at improving mitochondrial function and metabolic health.
See Also[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian